horizon discovery group plc lse hzd gene editing company designs engineers genetically modified cells applies research clinical applications human health horizon offers human disease models reagents derived geneticallyengineered cells customers may use gain knowledge genetic drivers disease develop novel drugs cell therapies targeted genetic drivers develop companion diagnostics predict patient response clinic horizon headquartered cambridge uk listed london stock exchange aim market ticker hzd horizon signed agreements december january mammoth biosciences combine mammoths intellectual property crispr horizons expertise chinese hamster ovary perkinelmer acquired horizon discovery million million november due perkinelmer split since may horizon discovery part revvity gene editing process specific changes made sequence gene within context host cell editing code patientderived cell introduce repair genetic change believed drive disease patient disease reproduced laboratory setting letting researchers ask important biological questions potential drugs cell therapies earlier drug discovery process gene editing platform horizon able alter genes human mammalian cell lines horizon offers cell line pairs model mutations found genetically based diseases patientsinatesttube may used identify effect individual compound genetic mutations drug activity patient responsiveness resistance may lead prediction patient subgroups respond currently available future drug treatments built engineered cells act product manufacturing engines yielding related cell reagent products used research tools molecular diagnostic reference standards means generate advanced vivo models httpsenwikipediaorgwikihorizondiscovery